Hotline: 1800 102 2007
Hotline: 1800 102 2007
Oct, 11 2018

Lilly India enters the autoimmune segment with Olumiant

Olumiant will be available in India starting October 2018 in 4mg and 2mg dosage forms.

Lilly India enters the autoimmune segment with Olumiant

Eli Lilly and Company (India) Pvt. Ltd. (Lilly India) has announced the launch of Olumiant (baricitinib), marking the company’s entry into the autoimmune segment in India.

Olumiant (baricitinib) is a once-daily oral medication for the treatment of adults with moderate-to-severe active Rheumatoid Arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Olumiant may be used as monotherapy or in combination with methotrexate.

Olumiant will be available in India starting October 2018 in 4mg and 2mg dosage forms. It is approved in more than 50 countries across the world.

Luca Visini, Managing Director, Eli Lilly and Company India, said, "Few days ahead of World Arthritis Day, Lilly India is excited to announce the introduction of its innovative therapy for patients living with Rheumatoid Arthritis. It is an announcement that builds on our heritage and commitment to India, a 25 years strong legacy of making life better and addressing the unmet needs of patients living with chronic diseases."

"People with Rheumatoid Arthritis continue to struggle with the debilitating effects of the disease, endure pain and do not achieve disease management goals. This can lead to long-term joint damage and even disability. Olumiant is an effective, advanced once-daily oral treatment option for people suffering from Rheumatoid Arthritis who have not responded well to conventional DMARDs. In clinical trials, Olumiant has proven efficacy and demonstrated rapid and significant improvement in patient-related outcomes such as pain, fatigue and joint stiffness," he added.

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Preschools
    About Us: PLUTOKIDS, the "Kids Planet", was set on it first..
    Locations looking for expansion Kolkata
    Establishment year 2009
    Franchising Launch Date 2020
    Investment size Rs. 10lac - 20lac
    Space required 1500
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Kolkata Kolkata
  • Healthcare & Medical Products
    About: Swayos Aushudh is the brand that represents Koye Pharmaceuticals in..
    Locations looking for expansion Maharashtra
    Establishment year 2020
    Franchising Launch Date 2020
    Investment size
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater Mumbai Maharashtra
  • Quick Service Restaurants
    About Us: Chatkaraa By Have A Dream Food, which aims at..
    Locations looking for expansion Madhya pradesh
    Establishment year 2018
    Franchising Launch Date 2018
    Investment size Rs. 5lac - 10lac
    Space required 200
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Indore Madhya pradesh
  • Quick Service Restaurants
    BUILDING INDIAS LARGEST CLOUD KITCHEN PLATFORM WITH KEY CUISINE CATEGORIES..
    Locations looking for expansion Maharashtra
    Establishment year 2019
    Franchising Launch Date 2020
    Investment size Rs. 20lac - 30lac
    Space required 250
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities